Pantakind Flux Capsule

Pantakind Flux Capsule is a combination of two medicines such as Cinitapride (3mg) and Pantoprazole (40mg). It is used to treat conditions like gastroesophageal reflux disease (Acid reflux) and non-ulcer dyspepsia (indigestion).

It works by reducing the amount of acid in the stomach which helps in relief of acid related indigestion & heartburn. This capsule also neutralizes acid & promotes easy passage of gas to reduce stomach discomfort.

It should be taken in dose and duration as advice by the doctor. Don't take more than the recommended dose.​

• Treatment of Gastroesophageal reflux disease (Acid reflux)
• Non-ulcer dyspepsia (indigestion)

Most side effects of Pantakind Flux Capsule do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.

Common side effects include:

• Headache
• Diarrhea
• Stomach pain
• Fatigue
• Dryness in mouth
• Constipation

• The dosage and duration of the Pantakind Flux Capsule are decided by the doctor based on the severity of the condition and other health factors. Take this tablet on an empty stomach for better results.
• Before starting this medicine, please inform your doctor about your medical history. If you experience any signs and symptoms while eating this medication that are not manageable, do not ignore those symptoms because they may lead to a higher risk.
  

• Pantakind Flux Capsule is a combination of two medicines such as Cinitapride (3mg) and Pantoprazole (40mg). In which Cinitapride known as prokinetic agent works on the upper digestive system to make the stomach and intestines flow more freely, making it easier for food to pass through the stomach.
• Also, pantoprazole is a proton pump inhibitor (PPI) which help to treat acid-related indigestion and heartburn by lowering the amount of acid production in the stomach.​​
  

• Jadhav, J. S., Vassa, S. P., & Jain, H. K. (2012). Development and validation of a RP-HPLC method for simultaneous determination of pantoprazole and cinitapride in antiulcer formulation. Int J Pharm Pharm Sci, 4(Suppl 4), 657-9. 
• Patil, V. K. (2013). Statistical Evaluation of NP-HPTLC and RP-HPTLC Method for the Simultaneous Estimation of Cinitapride and Pantoprazole in Bulk and in Capsule Formulation* Vijay K. Patil** Jineetkumar B. Gawad.
• Vidyadhara, S., Rao, Y. S., Ramu, A., Sasidhar, R. L., & Ramya, A. J. (2013). Method development and validation for the simultaneous estimation of cinitapride and pantoprazole in solid dosage forms by RP-HPLC. Oriental Journal of Chemistry, 29(3), 1213.
• Macharla, S., & Bairam, R. (2018). Analytical method development and validation for simultaneous estimation of cinitapride hydrogen tartrate and pantoprazole sodium in pharmaceutical dosage form by RP-HPLC. Der. Pharma. Chemica, 10, 1123-1128. https://www.derpharmachemica.com/pharma-chemica/analytical-method-development-and-validation-for-simultaneous-estimation-of-cinitapride-hydrogen-tartrate-and-pantoprazole-sodium-15273.html
• SASIDHAR, R. L., & RAMYA, A. J. Method Development and Validation for the Simultaneous Estimation of Cinitapride and Pantoprazole in Solid Dosage Forms By RP-HPLC. https://www.orientjchem.org/vol29no3/method-development-and-validation-for-the-simultaneous-estimation-of-cinitapride-and-pantoprazole-in-solid-dosage-forms-by-rp-hplc/